Structures by: Çalışkan N.
Total: 26
2-{[4-(3-Methyl-3-mesitylcyclobutyl)thiazol]hydrazono}-1,2-diphenylethanol ethanol solvate
C31H33N3OS,C2H6O
Acta Crystallographica Section E (2006) 62, 7 o2762-o2764
a=9.0997(11)Å b=9.9104(14)Å c=17.540(2)Å
α=92.876(10)° β=100.365(10)° γ=105.410(10)°
2-Amino-4-(3-methyl-3-p-xylylcyclobutyl)-1,3-thiazole
C16H20N2S
Acta Crystallographica Section E (2006) 62, 1 o174-o176
a=20.7083(11)Å b=20.7083(11)Å c=18.2954(10)Å
α=90.00° β=90.00° γ=120.00°
Bis{1-[(4-methoxyphenyl)amino]-2-methylglyoximato-κ^2^N,N}nickel(II)
C20H24N6NiO6
Acta Crystallographica Section E (2005) 61, 9 m1866-m1868
a=8.8819(7)Å b=5.2497(3)Å c=24.216(2)Å
α=90.00° β=106.165(7)° γ=90.00°
N-(3-Chloro-4-Metoxyphenyl)-N'-Hydroxy-2-Oxo-2-Phenylacetamidine
C15H13ClN2O3
Acta Crystallographica Section E (2003) 59, 10 o1532-o1534
a=5.0135(7)Å b=12.7483(11)Å c=22.495(3)Å
α=90.00° β=91.553(11)° γ=90.00°
N-(1,3-Benzothiazol-2-yl)-4-(dimethylamino)benzylamine
C16H15N3S
Acta Crystallographica Section E (2004) 60, 11 o2090-o2092
a=11.7771(8)Å b=22.6876(12)Å c=11.7725(9)Å
α=90.00° β=116.822(5)° γ=90.00°
Bis[N-(2,6-dimethylphenyl)aminophenylglyoximato-κ^2^N,N]nickel(II) dimethyl sulfoxide solvate
C32H32N6NiO4,C2H6OS
Acta Crystallographica Section E (2004) 60, 9 m1334-m1336
a=13.2381(11)Å b=7.8171(4)Å c=16.5034(14)Å
α=90.00° β=94.654(7)° γ=90.00°
1-[3-Methyl-3-(2,4,6-trimethylphenyl)cyclobutyl]-2-(thiomorpholin-4-yl)ethanone
C20H29NOS
Acta Crystallographica Section E (2005) 61, 8 o2401-o2402
a=13.4594(10)Å b=9.8855(5)Å c=14.0878(11)Å
α=90.00° β=91.080(6)° γ=90.00°
1,4-Bis{[(2Z)-2-(3-mesityl-3-methylcyclobutyl)-2-one thiosemicarbazono]ethyl} piperazine dimethylsulfoxide disolvate
C38H56N8S2,2C2H6OS
Acta Crystallographica Section E (2005) 61, 8 o2384-o2386
a=17.861(11)Å b=13.386(6)Å c=20.451(13)Å
α=90.00° β=91.744(5)° γ=90.00°
2-(Benzothiazol-2-yliminomethyl)-6-methoxyphenol
C15H12N2O2S
Acta Crystallographica Section E (2004) 60, 8 o1414-o1416
a=13.0117(12)Å b=6.3408(4)Å c=17.5237(15)Å
α=90.00° β=110.854(7)° γ=90.00°
3-[(2,4-Dinitrophenyl)hydrazono]butan-2-one oxime
C10H11N5O5
Acta Crystallographica Section E (2004) 60, 8 o1307-o1309
a=10.1400(16)Å b=12.3079(19)Å c=10.6624(18)Å
α=90.000° β=110.950(12)° γ=90.000°
S,S'-Bis(methoxycarbonylmethyl)dithioglyoxime monohydrate
C8H12N2O6S2,H2O
Acta Crystallographica, Section E (2004) 60, 8 o1347-o1349
a=8.6173(15)Å b=5.2953(7)Å c=15.588(3)Å
α=90.00° β=93.214(14)° γ=90.00°
2-({4-[3-Methyl-3-(2,4,6-trimethylphenyl)cyclobutyl]-3H-thiazol-2- ylidene}hydrazonomethyl)benzene-1,4-diol ethanol solvate
C24H27N3O2S,C2H6O
Acta Crystallographica Section E (2005) 61, 4 o1158-o1160
a=7.5304(9)Å b=12.5739(16)Å c=14.5935(18)Å
α=65.678(9)° β=84.257(10)° γ=89.335(10)°
1,1'-(Propane-1,3-diyl)bis[2-(methylsulfanyl)-1H-benzimidazole] dihydrate
C19H20N4S2,2(H2O)
Acta Crystallographica Section E (2007) 63, 1 o100-o102
a=9.2655(7)Å b=9.9754(7)Å c=11.2980(8)Å
α=102.125(6)° β=93.415(6)° γ=96.443(6)°
4-Chloro-2-[(4-phenyl-thiazol-2-yl)-hydrazonomethyl]-phenol
C16H12ClN3OS
Acta Crystallographica Section E (2006) 62, 11 o4889-o4890
a=6.5776(4)Å b=11.2455(8)Å c=20.2612(11)Å
α=90.00° β=101.400(4)° γ=90.00°
Diclorobis(2-aminobenzothiazole-κN)cobalt(II)
C14H12Cl2CoN4S2
Acta Crystallographica Section E (2006) 62, 9 m2313-m2315
a=11.7144(9)Å b=7.3595(4)Å c=20.0240(15)Å
α=90.00° β=96.454(6)° γ=90.00°
{6,6'-Dimethoxy-2,2'-[ethane-1,2-diylbis(nitrilomethylidyne)]diphenolato}- (ethanol)dioxouranium(VI)
C20H24N2O7U
Acta Crystallographica Section E (2006) 62, 12 m3163-m3164
a=9.2132(4)Å b=23.6595(10)Å c=19.7075(10)Å
α=90.00° β=90.00° γ=90.00°
[(2,4-Dinitrophenyl)hydrozono](phenyl)acetaldehyde oxime monohydrate
C14H11N5O5,H2O
Acta Crystallographica Section E (2007) 63, 2 o582-o584
a=17.2299(19)Å b=7.0635(12)Å c=13.5311(15)Å
α=90.00° β=109.629(8)° γ=90.00°
2-[Benzoyl(hydroxyimino)methylamino]benzoic acid
C15H12N2O4
Acta Crystallographica Section C (2004) 60, 4 o263-o264
a=20.6850(19)Å b=13.1680(13)Å c=10.488(11)Å
α=90.00° β=101.921(5)° γ=90.00°
(Benzofuran-2-yl)(3-methyl-3-phenylcyclobutyl)methanone
C20H18O2
Acta Crystallographica Section C (2004) 60, 7 o509-o510
a=6.1497(7)Å b=14.6894(19)Å c=16.922(2)Å
α=90.00° β=92.600(10)° γ=90.00°
N^1^-(4-tert-Butylphenyl)-N^2^-hydroxy-α-oxo-α-phenylacetamidine
C18H20N2O2
Acta Crystallographica Section C (2004) 60, 9 o702-o704
a=6.4331(10)Å b=10.7150(15)Å c=12.299(2)Å
α=75.054(12)° β=82.120(12)° γ=77.258(11)°
N^1^-(4-nitrophenyl)-N^2^-hydroxy-α-oxo-α-phenylacetamidine hemihydrate
C14H11N3O4,0.5H2O
Acta Crystallographica Section C (2004) 60, 9 o702-o704
a=6.8298(5)Å b=15.5454(15)Å c=26.097(2)Å
α=90.00° β=92.080(7)° γ=90.00°
4-Bromo-2-{[4-(3-mesityl-3-methylcyclobutyl)thiazol-2- yl]hydrazonomethyl}phenol
C24H26BrN3OS
Acta Crystallographica Section C (2005) 61, 12 o725-o727
a=8.3589(5)Å b=11.9903(7)Å c=24.1438(14)Å
α=75.507(5)° β=86.063(5)° γ=77.418(5)°
N^1^-(4-Bromophenyl)-N^2^-hydroxy-2-oxo-2-phenylacetamidine
C14H11BrN2O2
Acta Crystallographica Section C (2005) 61, 5 o343-o344
a=21.593(5)Å b=13.328(5)Å c=9.352(5)Å
α=90.000(5)° β=104.008(5)° γ=90.000(5)°
N^1^-(2,6-Dimethylphenyl)-N^2^-hydroxy-α-oxo-α-phenylacetamidine
C16H16N2O2
Acta Crystallographica Section C (2004) 60, 2 o115-o117
a=8.1002(10)Å b=7.8837(10)Å c=23.108(3)Å
α=90° β=90.828(10)° γ=90°
Ammonium O,O-dicyclohexyl phosphorodithioate
H4N1,C12H22O2PS2
Acta Crystallographica Section C (2006) 62, 3 o145-o147
a=15.0755(11)Å b=10.6965(5)Å c=10.5305(7)Å
α=90.00° β=107.123(5)° γ=90.00°
Diacetatobis(2-aminobenzothiazole-κN)cobalt(II)
C18H18CoN4O4S2
Acta Crystallographica Section C (2005) 61, 7 m342-m343
a=8.3049(4)Å b=27.1833(16)Å c=8.9868(5)Å
α=90.00° β=90.00° γ=90.00°